Hemostasis (Coagulation) Analyzer Market is poised to value USD 5921 million by 2028 end at a CAGR of 5.7% during the forecast period 2022 to 2028.

Testing for blood clotting is used to diagnose problems with the hemostasis system. The medical laboratory assessor known as a coagulometer is used to examine the hemostasis system. The expansion of blood plasma or the presence of blood clots in the blood is detected by new coagulometers using a variety of starting points and observation techniques. The method of assessing the hemostasis system developed approximately fifty years ago has been supported by the majority of coagulometers used in laboratory research. The majority of these techniques are excellent at identifying flaws in one hemostasis component without diagnosing other potential flaws. The thrombosis calculation, or sympathy for the patient's prethrombotic state, is another drawback of the definite hemostasis system evaluator. The growing population base suffering from the syndrome related with standard of living and lifestyle, as well as recurrent blood illnesses, is predicted to contribute to the rising need for coagulation analyzers. Moreover, it is anticipated that growing awareness of these disorders would speed up diagnostic development and preventative care oversight, which is expected to significantly increase testing volume. The emerging nations that are the subject of research and study are currently through an example shift and spending a significant amount of public money to buy and set up such medical technology in their local healthcare facilities. Future trends are expected to include an ageing population, an increase in chronic illnesses, and a rapid growth in foreign investments. The market for hemostasis/coagulation analyzers is anticipated to expand as a result of factors including the rise in cardiovascular illnesses and the ageing population worldwide.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Hemostasis (Coagulation) Analyzer Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Hemostasis (Coagulation) Analyzer Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Hemostasis (Coagulation) Analyzer Market:

  • Alere Inc.
  • Nihon Kohden Corporation
  • Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd.)
  • Siemens Healthcare (A Division of Siemens AG)
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Diagnostica Stago Sas
  • Helena Laboratories
  • Instrumentation Laboratory (A Division of the Werfen Group)
  • International Technidyne Corporation (ITC)

(Note: The list of the major players will be updated with the latest market scenario and trends)

Hemostasis (Coagulation) Analyzer Market Segmentation:

By Product
• Clinical Laboratory Analyzers
• Systems
  o Automated Systems
  o Semi-automated Systems
  o Manual Systems
• Consumables
  o Reagents
  o Standards, Controls and Calibrations
• Analyzers for Point-of-Care Testing

By Test

  • Prothrombin Time
  • Fibrinogen
  • Activated Partial Thromboplastin Time
  • Activated Clotting Time
  • D Dimer
  • Platelet Function
  • Anti-factor Xa
  • Heparin & Protamine Dose Response Test for ACT
  • Other Coagulation Tests

By Technology

  • Mechanical
  • Optical
  • Electrochemical
  • Other Technologies

By End Users

  • Clinical Laboratories
  • POC
  • Others End Users

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Hemostasis (Coagulation) Analyzer Market Sample Video:

Competitive Landscape:

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

FutureWise Key Takeaways:

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

Objectives of the Study:

  • To provide with an exhaustive analysis on the Hemostasis (Coagulation) Analyzer Market By Product, By Test, By Technology, By End Users and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com


Need Assistance


UK : +44 141 628 9353
US : +1 347 709 4931


Contact Sales

What you get

  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included

  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics